替诺福韦与以齐多夫定为基础的方案之间的免疫学结果:一项回顾性队列研究

Archives of community medicine and public health Pub Date : 2019-07-11 DOI:10.17352/2455-5479.000052

Meshack Lugoba, Manase Kilonzi, G. Bwire, Pacifique Ndayishimiye, W. Mikomangwa, H. Mlyuka, A. Marealle, R. Mutagonda, K. Mwambete

{"title":"替诺福韦与以齐多夫定为基础的方案之间的免疫学结果:一项回顾性队列研究","authors":"Meshack Lugoba, Manase Kilonzi, G. Bwire, Pacifique Ndayishimiye, W. Mikomangwa, H. Mlyuka, A. Marealle, R. Mutagonda, K. Mwambete","doi":"10.17352/2455-5479.000052","DOIUrl":null,"url":null,"abstract":"Background: Since 2013, Tenofovir (TDF) and Zidovudine (AZT) based regimen are alternatively \nused as a fi rst line for treatment of HIV in Tanzania. CD4+ cells count, which is recommended after every \nsix months monitors the immunological progression, and used as one of the indicators of treatment \nprogression. However, there is little literature available information to compare the immunological \noutcomes of these two regimens.","PeriodicalId":87221,"journal":{"name":"Archives of community medicine and public health","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective cohort study\",\"authors\":\"Meshack Lugoba, Manase Kilonzi, G. Bwire, Pacifique Ndayishimiye, W. Mikomangwa, H. Mlyuka, A. Marealle, R. Mutagonda, K. Mwambete\",\"doi\":\"10.17352/2455-5479.000052\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Since 2013, Tenofovir (TDF) and Zidovudine (AZT) based regimen are alternatively \\nused as a fi rst line for treatment of HIV in Tanzania. CD4+ cells count, which is recommended after every \\nsix months monitors the immunological progression, and used as one of the indicators of treatment \\nprogression. However, there is little literature available information to compare the immunological \\noutcomes of these two regimens.\",\"PeriodicalId\":87221,\"journal\":{\"name\":\"Archives of community medicine and public health\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of community medicine and public health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17352/2455-5479.000052\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of community medicine and public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/2455-5479.000052","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

背景：自2013年以来，基于替诺福韦（TDF）和齐多夫定（AZT）的方案在坦桑尼亚被交替用作治疗HIV的一线药物。CD4+细胞计数，建议每六个月监测一次免疫进展，并用作治疗进展的指标之一。然而，很少有文献可以比较这两种方案的免疫结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective cohort study

Background: Since 2013, Tenofovir (TDF) and Zidovudine (AZT) based regimen are alternatively used as a fi rst line for treatment of HIV in Tanzania. CD4+ cells count, which is recommended after every six months monitors the immunological progression, and used as one of the indicators of treatment progression. However, there is little literature available information to compare the immunological outcomes of these two regimens.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Archives of community medicine and public health

自引率

0.00%

发文量